Following recent updates to ICH-E6(R2), Roche is currently developing pre-defined Quality Tolerance Limits taking into account medical and statistical considerations. If anyone is interesting in sharing their experiences or collaborating, we would love to hear from you.
Please contact tammy.mciver@roche.com for further information.
Many Thanks
Tammy
